Immune tolerance induction using a factor VIII/von Willebrand factor concentrate (BIOSTATE®), with or without immunosuppression, in Australian paediatric severe haemophilia A patients with high titre inhibitors: A multicentre, retrospective study.
Role of coagulation-associated processes on FVIII immunogenicity in a mouse model of severe hemophilia A.
O-Phospho-l-Serine mediates Hyporesponsiveness toward FVIII in Hemophilia A-Murine Model by Inducing Tolerogenic Properties in Dendritic Cells.
[Carriers of haemophilia: Experience of a French university hospital.]
Prophylaxis in adult patients with severe haemophilia A.
[Re: A man in his 80s with muscle stiffness and skin bleeding].
Increased venous thrombosis incidence in pregnancies after in vitro fertilization.
Efficacy of yttrium-90 synovectomy across a spectrum of arthropathies in an era of improved disease modifying drugs and treatment protocols.
The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.
This page was last updated September 8, 2010 and is maintained by Betsy Wilson
Vanderbilt University is committed to principles of equal opportunity and affirmative action. Copyright 2014 © Vanderbilt University Medical Center.